Posts

Mayor Jim Kenney; Steinar Nerbovik of Philly Shipyard, Inc., Majority Leader Steny Hoyer; Congresswoman Mary Gay Scanlon at Philly Shipyard. Photo credit: Albert Lee for the City of Philadelphia

House Majority Leader Hoyer and Congresswoman Scanlon Tour the Navy Yard

Congresswoman Mary Gay Scanlon (PA-05) today welcomed Congressman Steny H. Hoyer (MD-05), Majority Leader for the U.S. House of Representatives, to the Philadelphia Navy Yard. Alongside officials from the City of Philadelphia and PIDC, Hoyer and Scanlon toured the Navy Yard, met with representatives from two key employers — Philly Shipyard, Inc. and Iovance Biotherapeutics, and discussed ongoing federal investments at the Navy Yard.

Mayor Jim Kenney; Steinar Nerbovik of Philly Shipyard, Inc., Majority Leader Steny Hoyer; Congresswoman Mary Gay Scanlon at Philly Shipyard. Photo credit: Albert Lee for the City of Philadelphia

“The Philadelphia Navy Yard is emerging as a center of economic activity for our region,” said Rep. Scanlon. “I was honored to host Majority Leader Hoyer today to show him how this area is leading Philadelphia’s transition from its industrial roots to the economy of the future. Once a federal shipyard run by the Navy, the area sat dormant after closing in the 1990s, but now boasts employers spanning industries from shipbuilding and manufacturing to life sciences and more. As the U.S. Representative for the Navy Yard, I’m proud to champion federal investments to support the work of PIDC and its partners to transform this space and bring more jobs to our region.”

Visit to Iovance Biotherapeutics. Photo credit: Albert Lee for the City of Philadelphia

“I was proud to join Rep. Scanlon at Philadelphia’s Navy Yard today to see the extraordinary work being done to create a regional hub for innovation and economic growth,” said Majority Leader Hoyer. “Securing the return of Community Project Funding in the Fiscal Year 2022 appropriations process was a big win for members and for every congressional district, where important local projects are again able to receive the support they deserve in a way that is fully transparent and accountable. The funding Rep. Scanlon brought home to the Navy Yard is a wonderful example of that, and it is an example of House Democrats’ efforts to help more businesses and workers Make It In America as well. I want to thank her for her leadership and her hard work to help Pennsylvanians and all Americans access economic opportunities and get ahead.”

Majority Leader Steny Hoyer; Congresswoman Mary Gay Scanlon; Steinar Nerbovik of Philly Shipyard, Inc., Anne Bovaird Nevins of PIDC; at Philly Shipyard’s Training Center. Photo credit: Albert Lee for the City of Philadelphia

In March, Scanlon secured $525,000 for PIDC’s Navy Yard Skills Initiative in the Fiscal Year 2022 federal government funding package. It is one of 10 Community Project Funding awards Scanlon delivered for her district. By creating unique, customized training programs, Navy Yard Skills Initiative builds on the model developed by the West Philadelphia Skills Initiative to connect unemployed and underemployed Philadelphia residents to permanent employment with Navy Yard employers. Thanks to the Community Project Funding secured by Scanlon, the Navy Yard Skills Initiative will be able to run for another full year. Since the program’s initial recruitment in February 2021, Navy Yard Skills Initiative has graduated four cohorts of trainees — totaling 53 people — with 98% of graduates receiving full-time job offers with employers including Philly Shipyard, Inc. and Tasty Baking Company after completing their training.

Looking inside Dry Dock 4 at Philly Shipyard, Inc. Photo credit: Albert Lee for the City of Philadelphia

Scanlon has also led the charge in Congress to help Philly Shipyard, Inc. (PSI) secure federal shipbuilding contracts after the Shipyard fell dormant in 2018 and suffered massive layoffs. In April 2020, the shipyard was awarded an initial contract valued at $630 million to build the first two ships in a five-ship series of U.S. DOT Maritime Administration (MARAD) National Security Multi-Mission Vessels (NSMVs). Since then, Scanlon has continued to advocate for additional contracts to be awarded to PSI, which has now been contracted to complete all five ships in the NSMV fleet. The total value for these five training vessels is approximately $1.5 billion. When Scanlon was first elected in 2018, Philly Shipyard only had around 80 employees. The contract for the NSMV program has allowed PSI to reconstitute its workforce, which currently stands around 1,200 and is expected to reach full capacity in mid-2022.

Photos are available here for media use.

Contact: Lauren Cox, 202-880-2680, Lauren.Cox@mail.house.gov

Groundbreaking ceremony with Ensemble/Mosaic, Oxford, PIDC, and Councilmember Kenyatta Johnson

Ensemble/Mosaic and Oxford Properties Group Break Ground on Speculative R & D Lab Building

Ensemble/Mosaic, a joint venture between Ensemble Real Estate Investments and Mosaic Development Partners, and Oxford Properties Group (“Oxford”), a leading global real estate investor, asset manager and business builder, have broken ground on 1201 Normandy Place, a speculative 137,000 square foot R & D lab building at the Navy Yard in Philadelphia. The project represents the first new development initiated as part of Ensemble/Mosaic and Oxford’s recently executed strategic partnership.

“1201 Normandy represents a significant milestone for the Navy Yard, our new partnership with Mosaic and Oxford, and Philadelphia’s life sciences community,” said Mark Seltzer, Senior Vice President, Development-East at Ensemble. “The building will play a critical role in the life science ecosystem of the campus by creating space for smaller gene and cell therapy users and providing a place to grow as their business evolves towards commercialization and manufacturing. This is the right product, at the right time in the right location, and we are already experiencing strong interest.”

1201 Normandy Place

“The Navy Yard is a critical asset to Philadelphia’s life science community,” said Philadelphia City Councilmember Kenyatta Johnson, whose Second Council District includes the Navy Yard.  “The development of this new 137,000 square foot laboratory and office building here at 1201 Normandy Place is the first development by Ensemble Real Estate Investments and Mosaic Development Partners.  The lab building is tailored specifically to gene and cell therapy companies and will further drive economic growth at the Navy Yard, which is a major economic engine of our city.”

1201 Normandy Place is the first speculative multi-tenant R & D lab building at the Navy Yard. The building was designed in consultation with CRB, a leading lab designer, to be the most sophisticated lab building in the region optimized for cell and gene therapy R & D companies, while maintaining the flexibility to accommodate all users. The modern four-story facility will feature 137,000 square feet of highly customizable lab space and will be able to support life science customers ranging from 5,000-35,000 square feet per floor. Special user-specific considerations include 15’-16’ floor-to-floor ceiling heights, predetermined GMP space, structural integrity that minimizes vibration and two loading docks. The robust utility and safety features include a central plant HVAC system with water cooled chillers, customizable electrical output and layout as well as built-in emergency power. Occupants will also have access to collaborative workspace, an outdoor balcony on each floor and a ground level cafe. The building is projected to achieve LEED Gold Certification.  CBRE is leading the marketing  efforts for 1201 Normandy Place.

“Today’s groundbreaking builds on our partnership’s considerable momentum, as we take a major step towards delivering a world-class life science innovation hub at the heart of the Navy Yard,” said Chad Remis, Executive Vice President, North America at Oxford. “The speed at which we’ve advanced this project is testament to the relationship between Oxford and Ensemble/Mosaic—in both our vision for the project, as well as our shared conviction in Philadelphia and its continued emergence as one of the premier global biopharma markets.”

1201 Normandy will allow smaller-scale gene and cell therapy companies to take space in the Navy Yard’s thriving life science community. Currently, it is home to many world-class and well-established gene and cell therapy firms including Iovance Biotherapeutics, Adaptimmune Therapeutics PLC, WuXi Advanced Therapies Coriell Life Sciences, Vinta Bio, Inc., and is the regional headquarters of Ben Franklin Technology Partners.

“The depth of our collective development experience, this unparalleled location and our ability to move quickly are tremendous advantages for us,” said Greg Reaves, CEO and Co-Owner, Mosaic. “We designed 1201 Normandy to be at the leading edge of R & D lab space, offering customers superior utility packages and safety features. This building will truly be transformational to the life science community and the Navy Yard as a whole.”

Groundbreaking ceremony with Ensemble/Mosaic, Oxford, PIDC, and Councilmember Kenyatta Johnson

Ensemble/Mosaic and Oxford

Recently, Ensemble/Mosaic and Oxford Properties Group entered into a strategic partnership which will, over time, own and develop up to 3 million square feet of life science properties at the Navy Yard in Philadelphia. The agreement includes Oxford’s investment in five existing life science assets owned by Ensemble Real Estate Investments, and Ensemble/Mosaic’s two initial life science properties, of which 1201 Normandy is the first. In addition, Oxford will look to partner in all future life science projects on sites controlled by Ensemble/Mosaic at the Navy Yard. The deal represented Oxford’s first investment in Philadelphia and further expands the firm’s extensive life science portfolio, which includes over US$2 billion of investment activity in North America since the start of 2021.

PIDC Senior Vice President Kate McNamara considers the Ensemble/Mosaic and Oxford partnership a boon that will help continue to grow the ecosystem of the Navy Yard.

“Developing a speculative life science building that can house multiple users illustrates the strength of the market in Philadelphia and the strong interest by companies to take advantage of all the Navy Yard has to offer,” said McNamara. “This is a big milestone for the Navy Yard, Ensemble/Mosaic, Oxford, and PIDC that will create a landscape for lifesaving work and job opportunities for all Philadelphians. We’re at an important intersection of what the city needs and what will benefit the world, and it’s an exciting moment.”

Ensemble/Mosaic at the Navy Yard

In 2020, Ensemble/Mosaic announced plans for its US$2.6 billion development plan, designed to further establish the Navy Yard as a vibrant and inclusive mixed-use community. Through its agreement with PIDC—Philadelphia’s public-private economic development corporation, which oversees all management and development of the Navy Yard, the joint venture plans for approximately 3,000 residential units and more than 3 million square feet of life science manufacturing, R & D, office, hotels, makerspace and retail space when complete. In addition to 1201 Normandy and 333 Rouse, the $400+ million first phase includes the development a three-building residential complex with ground floor retail (including an AVE in partnership with Korman Communities) and a signature adaptive reuse hotel.

Sumit Verna, Iovance iCTC site head, at the ribbon cutting ceremony. He is joined by Fred Vogt, Iovance CEO, Governor Tom Wolf, and Mayor Jim Kenney.

Iovance Biotherapeutics Celebrates Grand Opening of Iovance Cell Therapy Center (iCTC)

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), is celebrating the official opening of the Iovance Cell Therapy Center (iCTC). The iCTC, located at the Philadelphia Navy Yard, is the first centralized, scalable, state-of-the-art manufacturing facility dedicated to producing TIL cell therapies for patients with solid tumor cancers. The current capacity is expected to meet potential demand for thousands of patients per year with multiple types of cancers, including clinical trial patients and future commercial patients.

Frederick Vogt, Ph.D., J.D., Interim President and Chief Executive Officer of Iovance, stated, “Since Iovance was founded, we have been dedicated to advancing novel cell therapies for patients with solid tumor cancers. As the hub of cell and gene therapy and the home of leading hospitals and academic centers, Philadelphia became the city of choice for our internal manufacturing. A little over two years after breaking ground, iCTC is now one of the largest cell therapy manufacturing facilities in the world and may ultimately house hundreds of employees. We now have the capacity to supply broad access to TIL therapies for patients. I believe that the important ecosystem within Cellicon Valley will continue to contribute to our advancements to pioneer a new class of treatment for cancer.”

A ribbon cutting event celebrates the opening with special guests including Pennsylvania Governor Tom Wolf, Philadelphia Mayor Jim Kenney, and other government officials and collaborators within Cellicon Valley. Patients, caregivers, and patient advocacy organizations, including Melanoma Research Foundation (MRF), Melanoma Research Alliance (MRA) and the Society for Gynecological Oncology’s Foundation for Women’s Cancer cut the ribbon on behalf of everyone who is currently fighting cancer, and in memory of those who lost their battles with cancer.

Sumit Verna, Iovance iCTC site head, at the ribbon cutting ceremony. He is joined by Fred Vogt, Iovance CEO, Governor Tom Wolf, and Mayor Jim Kenney.

“The iCTC is a symbol of significant innovation and opportunity for the commonwealth as hundreds of new, high-paying jobs will ultimately be created at this facility,” said Governor Tom Wolf. “Iovance has already made a positive impact on the region and worked with a great sense of urgency to complete construction and begin initial manufacturing for patients with cancer.”

“The iCTC represents a new model in cell therapy manufacturing and bolsters Philadelphia’s reputation as a leading location for technology, innovation, and life sciences,” said City of Philadelphia Mayor Jim Kenney. “Iovance is a great example of what companies from around the country and the world may accomplish in establishing Philadelphia as the place to attract talent and grow their business.”

Located at 300 Rouse Boulevard and with approximately 136,000 square feet of space, the iCTC is among the largest cell therapy manufacturing facilities today. The iCTC is currently supplying Iovance clinical studies, and commercial manufacturing is expected to begin after initial product approval. The iCTC was developed and built by Gattuso Development Partners, LLC and the design and construction management firm CRB. Financial incentives were provided by the Commonwealth of Pennsylvania, the City of Philadelphia, and PIDC, including the site’s designation as a Keystone Opportunity Improvement Zone, which allows incentives for business development.

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte (TIL) therapy uses a patient’s own immune cells to attack cancer. TIL cells are extracted from a patient’s own tumor tissue, expanded through a proprietary process, and infused back into the patient. Upon infusion, TIL reach tumor tissue, where they attack cancer cells. The company has completed dosing in pivotal programs in patients with metastatic melanoma and cervical cancer. In addition, the company’s TIL therapy is being investigated in a registration-supporting study for the treatment of patients with locally advanced, recurrent or metastatic non-small cell lung cancer. Clinical studies are also underway to evaluate TIL in earlier stage cancers in combination with currently approved treatments, and to investigate Iovance peripheral blood lymphocyte (PBL) T cell therapy for blood cancers. For more information, please visit www.iovance.com.

Forward-Looking Statements

Certain matters discussed in this press release are “forward-looking statements” of Iovance Biotherapeutics, Inc. (hereinafter referred to as the “Company,” “we,” “us,” or “our”) within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). All such written or oral statements made in this press release, other than statements of historical fact, are forward-looking statements and are intended to be covered by the safe harbor for forward-looking statements provided by the PSLRA. Without limiting the foregoing, we may, in some cases, use terms such as “predicts,” “believes,” “potential,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “forecast,” “guidance,” “outlook,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes and are intended to identify forward-looking statements. Forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, many of which are outside of our control, that may cause actual results, levels of activity, performance, achievements and developments to be materially different from those expressed in or implied by these forward-looking statements. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled “Risk Factors” in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and include, but are not limited to, the following substantial known and unknown risks and uncertainties inherent in our business: the effects of the COVID-19 pandemic; risks related to the timing of and our ability to successfully develop, submit, obtain and maintain U.S. Food and Drug Administration (“FDA”) or other regulatory authority approval of, or other action with respect to, our product candidates, and our ability to successfully commercialize any product candidates for which we obtain FDA approval; preliminary and interim clinical results, which may include efficacy and safety results, from ongoing clinical trials or cohorts may not be reflected in the final analyses of our ongoing clinical trials or subgroups within these trials or in other prior trials or cohorts; the risk that enrollment may need to be adjusted for our trials and cohorts within those trials based on FDA and other regulatory agency input; the new version of the protocol which further defines the patient population to include more advanced patients in our cervical cancer trial may have an adverse effect on the results reported to date; the risk that we may be required to conduct additional clinical trials or modify ongoing or future clinical trials based on feedback from the FDA or other regulatory authorities; the risk that our interpretation of the results of our clinical trials or communications with the FDA may differ from the interpretation of such results or communications by the FDA; the acceptance by the market of our product candidates and their potential reimbursement by payors, if approved; our ability or inability to manufacture our therapies using third party manufacturers or our own facility may adversely affect our potential commercial launch; the results of clinical trials with collaborators using different manufacturing processes may not be reflected in our sponsored trials; the risk that unanticipated expenses may decrease our estimated cash balances and forecasts and increase our estimated capital requirements; and other factors, including general economic conditions and regulatory developments, not within our control.

CONTACTS

Iovance Biotherapeutics, Inc:
Sara Pellegrino, IRC
Vice President, Investor Relations & Public Relations
650-260-7120 ext. 264
Sara.Pellegrino@iovance.com

Solebury Trout:
Zara Lockshin
646.378.2960
zlockshin@soleburytrout.com

Chapel Block Images_11

Ensemble/Mosaic Announces Plans for Chapel Block, the First Residential Development at the Navy Yard Since the 1996 Base Closure

Ensemble/Mosaic today announced plans to develop the first residential complex to be built at the Philadelphia Navy Yard as part of its agreement with PIDC. The company plans to break ground on the project in 2022 and open the complex in 2024.

“Ensemble/Mosaic is on the cusp of reaching a longstanding, identity-shifting objective – to evolve the Navy Yard into a fully functioning Philadelphia neighborhood,” said Brian Cohen, Senior Vice President, Ensemble. “We are incredibly excited at the prospect of creating a vibrant and diverse residential community so people may further enjoy this unique location and all it has to offer.”

Located at 1200 Normandy Place, the complex, called Chapel Block, will include a seven-story building and two connected six-story buildings. In total, it will offer 611 luxury and mixed-income apartments offering 40 different unit sizes and bedroom configurations, and options for furnished and unfurnished units.

It will also include 75,000 square feet of indoor and outdoor resident amenity space and 26,000 square feet of space for restaurants and retail. All three buildings are designed to meet a minimum of LEED® Silver certification from the United States Green Building Council, providing for a sustainable and healthy living experience.

Design Informed by the Pandemic

“The pandemic was foremost in our thinking as we developed this project, keeping in mind the new realities of how people work, value outdoor access and are concerned about indoor ventilation,” said Leslie Smallwood-Lewis, Founder and Owner, Mosaic. “Home should be every resident’s ‘safe place,’ and our goal has been to incorporate as much as we can of what we have learned in the last 18 months so that residents will be comfortable and secure in their homes here.”

Some of the steps the team has taken include:

  • A significant number of units will include areas to accommodate working from home, with separate offices or built-in work areas.
  • Proximity to three parks: five-acre Central Green with a running track, outdoor table tennis, bocce, cross-fit station, amphitheater, and picnic areas; three-acre League Island Park, a natural and serene park for lounging and working; and eight-acre Marine Parade Grounds, a historic public space that provides fields for sport leagues, food trucks, and large outdoor events.
  • LEED certification with an emphasis on a healthy living environment with high indoor air quality.
  • Expanded building amenity offerings and areas to work from outside of apartments.

Chapel Block: A Community of Three Buildings, Dozens of Options

Chapel Block takes its name from the historic Chapel constructed by the Navy in 1942 on the southeast corner of the block to be developed.  The chapel is now occupied by the Chapel of the Four Chaplains and Memorial Foundation, dedicated to promoting interfaith cooperation and selfless service of individuals and organizations. It honors the moving story of four chaplains who died while saving many lives when The Dorchester, a U.S. Army transport ship (USAT), was sunk in the waters of Newfoundland during World War Two.

“One of the most interesting aspects of developing in the Navy Yard is that we are surrounded by critical U.S. history on a daily basis,” said Cohen. “This is a place filled with stories of bravery and heroism. It is an inspiring location and one we love to share with residents, employees and visitors.”

The seven-story building will be developed on the north end of the Chapel Block site in partnership with Korman Communities under their exciting residential real estate brand, “AVE.”

AVE Navy Yard will feature 265 luxury units, a portion of which will be reserved as flexible-stay, fully furnished apartments offered on a monthly basis for individuals who need a temporary living option. On-demand amenities will include a resort pool, media theatre, fire pit lounge, grilling stations, executive meeting spaces, a golf simulator, music studio, and pet spa.

“We are thrilled to partner with Ensemble/Mosaic on this exciting project,” said Bradley J. Korman, co-CEO of Korman Communities. “Philadelphia is our home, and we are honored to be a part of this incredible opportunity to develop what will become one of the most desirable locations to live, work, and play in the region.”

On the south end of Chapel Block, the two six-story buildings will form a mixed-income project containing 346 market rate and affordable units.  It is designed as two separate structures and will be connected on the ground floor by shared amenities including a fitness center, business center, lounge areas, a game area, a party room with gourmet kitchen, pet spa, and bike storage.  The connected buildings are situated around a private courtyard with lounge seating fire pits and grill stations.

“Chapel Block will change the Navy Yard in many exciting ways. This addition of new  mixed-income residential for the first time since the naval base was closed over two decades ago will serve not only the employees and visitors of the Navy Yard, but everyone who lives on site, too,” said Kate McNamara, PIDC’s Senior Vice President, Navy Yard.

The complex is designed by a partnership of two architectural firms, Philadelphia-based DIGSAU, the design architect, which has designed several buildings in the Navy Yard, and Moody Nolan, the architect of record, headquartered in Columbus, OH. Moody Nolan is the 2021 AIA Firm of the Year and the largest minority owned architecture firm in the country.

“Two exceptional architectural firms have banded together to bring us a design that will change the Navy Yard for decades by creating residential opportunities for people from all walks of life,” said Smallwood-Lewis. “We are excited that they have brought opportunity to many smaller and specialty firms, as more than 50% of the design work is being done by 15 different MBE/WBE-certified firms in Philadelphia and around the country.”

Through its development agreement with PIDC, Ensemble/Mosaic will redevelop 109 acres of land through renovation and ground-up construction, including Chapel Block. The developer will invest $2.6B – with all funds fully committed to ESG (environmental, social and governance) – over the next two decades, of which $1B has been commitment to DEI (diversity, equity and inclusion.)

After the naval base closure in 1996, the City of Philadelphia, PIDC, Philadelphia’s public-private economic development corporation and master developer of the Navy Yard, and its partners envisioned the redevelopment of the space into a thriving mixed-use campus, restoring it as an economic engine for the city. Over the last two decades, the Navy Yard has attracted 170 businesses employing more than 15,000 personnel.

Ensemble/Mosaic is working with PIDC and the U.S. Navy to complete the technical steps necessary to lift the residential deed restriction on this parcel.

“We thank our partners at the Navy for working with us to on this new development, which will further the Navy Yard’s position as one of Philadelphia’s most unique business campuses and evolving neighborhoods,” added McNamara.

Redevelopment of historic Building 624: Historic Core pedestrian plaza flanked by artisan makerspaces for authentic local retail. Credit: Grgoundswell

Ensemble/Mosaic Launches a Bold, Systemic $2.6B Environmental, Social & Governance Commitment at the Navy Yard

Partnership has Committed $7.5 Million to 21 Certified Minority and Women, Design & Engineering Firms to Lift Off $1B Diversity, Equity & Inclusion Pledge

Ensemble Real Estate Investments and Mosaic Development Partners (Ensemble/Mosaic) today announced it has launched its ambitious Environmental, Social & Governance (ESG) program at the Philadelphia Navy Yard, the bedrock of its plan to develop 109 acres of the campus.

“We believe our $2.6B ESG initiative to be one of the most significant commitments by any developer for any development in our country,” said Kam Babaoff, Co-Founder and Chairman of Ensemble Real Estate Solutions & Investments. “And, as part of this ambitious plan, we are committing $1B to diversity, equity and inclusion (DEI) initiatives – again, likely the largest pledge ever in our industry. Dedication to ESG, and specifically the DEI principals within it, will drive lasting positive change in this city because it will be built by Philadelphians for Philadelphians.”

PIDC, Philadelphia’s public-private economic development corporation and master developer of the Navy Yard, and Ensemble/Mosaic are partnering on the 2022 Philadelphia Navy Yard Plan Update. Ensemble/Mosaic will invest the $2.6 billion of development in the 1200-acre campus over the next two decades. The venture anticipates breaking ground on its first buildings – among them 1201 Normandy Place – in the fourth quarter of 2021.

A cornerstone of this ESG program is the partnership’s Diversity, Equity and Inclusion (DEI) strategy.

“PIDC set the tone for DEI in their request for proposal, and we felt inspired to create a plan with great scope and depth,” said Leslie Smallwood-Lewis, Principal of Mosaic, a minority-owned business enterprise. “Our DEI commitment will provide meaningful equity and capacity-building contracting opportunities for minority, women, veteran and disabled-owned business enterprises (MWVDBE) over the next two decades and we are excited to help create lasting change.”

Ensemble/Mosaic began deploying this strategy in the initial phase of development through the hiring of 20 local and national MWVDBE design and engineering firms such as Moody Nolan – the largest African American architecture firm in the nation and the “2021 AIA Firm of the Year”, Kelly Maiello and Rodriguez Consulting. Those commitments, representing approximately 50% ($7.5M) of the total allocation for design, have been made since the partnership was awarded the development rights by PIDC less than four months ago.

ESG Criteria as the North Star

ESG is a set of criteria created by an organization to guide socially responsible decisions. It includes environmental sustainability, such as impact on climate change or carbon footprint, recycling and water management; social impact through diversity, equity and inclusion (DEI), and organizational values; and governance, including partnership diversity, the auditing of DEI initiatives and  representation on boards and committees.

“From the moment we committed to answering the request for proposal from PIDC, ESG has been our north star,” said Greg Reaves, Principal of Mosaic. “Every decision we make, from design to development to neighborhood creation is through the lens of our ESG strategy.”

After the naval base closure in 1996, the City of Philadelphia, PIDC and its partners envisioned the redevelopment of the space into a thriving mixed-use campus, restoring it as an economic engine for the city. Over the last two decades, the Navy Yard has successfully attracted 150 businesses employing more than 15,000 personnel to the site with new development planned to further its position as one of Philadelphia’s most unique business campuses and evolving neighborhoods.

Through its development agreement with PIDC, Ensemble/Mosaic will redevelop 109 acres  of land through renovation and ground-up construction. The 20-year project includes the creation of additional office, laboratories and clean spaces, retail, restaurants and hotels, and residential buildings, parks, greenways and amenities.

“The Navy Yard has reestablished itself as a successful platform for job creation with a focus on innovation, production, and sustainability, and I commend PIDC and Ensemble/Mosaic on their shared vision and alignment of goals, which will further spur equitable growth in Philadelphia,” said Philadelphia Mayor Jim Kenney. “This unparalleled commitment to ESG sets the new standard for socially responsible, inclusive development in Philadelphia while providing countless benefits for Philadelphians for years to come.”

Bringing Meaningful, Measurable Change

Ensemble and Mosaic formed a partnership with the objective of focusing on redeveloping the Navy Yard by creating opportunities for diverse participants in every aspect of development.

To illustrate, Babaoff and Reaves broke down some of the many ESG-focused programs in motion or development, with a particular focus on DEI, such as:

  • Minority, Women, Veteran and Disabled-Owned Businesses Enterprises will equitably participate in every phase of the development cycle (design, construction and operations) at some of the highest levels ever achieved for a project of this size and scale. (See chart)
  • Minority Equity Investment ensures up-to-20% of the equity investment will be provided by minorities and minority-owned firms.
  • A Community Investment Platform will offer the opportunity for local low-and-moderate-income individuals to invest, through crowdfunding, collectively up to 5% of the equity in each project.
  • A Charitable Foundation, initially funded by a $1M commitment by Ensemble/Mosaic with continued funding from a percentage of the project’s net cash flow, will actively support and promote the development and economic empowerment of minorities and women.
  • An ongoing commitment to providing Housing Affordability for 15% of all residential units.
  • A minimum of a 35% Diverse Workforce during the construction of buildings with minority, female, veteran and disabled workforce.
  • A commitment to a minimum of 50% Local Workforce during construction from the Greater Philadelphia region.
  • MWVDBE Retail Opportunities by providing a minimum of 25% of all retail to firms with subsidized lease terms.
  • Internship program with local universities will bring opportunities to minority and female students in the Delaware Valley.

“The Navy Yard continues to be an economic engine for our region, and we are now focused on creating even more meaningful change. Ensemble/Mosaic is dedicating tremendous energy, time and financial commitment with its investment directed toward minority, women, disabled and veteran-owned companies,” said Councilmember Kenyatta Johnson, who represents the Navy Yard within the Second District. “This $1B pledge and each individual commitment will make an enormous difference to companies and individuals over the next 20 years.”

Pushing the Boundaries of Sustainability

“There is a long history of leadership around sustainability at the Philadelphia Navy Yard – from pilot programs for stormwater and autonomous shuttles to an 8MW peak-shaving battery back-up and Pennsylvania’s first community solar project, just to name a few,” said Kate McNamara, PIDC’s Senior Vice President, Navy Yard. “The campus already contains more than a dozen LEED certified buildings ranging from Certified to Double Platinum, and Ensemble/Mosaic’s commitment to sustainable development and management will continue to set the pace in our region and across the nation.”

Each Ensemble/Mosaic development project will be designed to achieve a LEED Silver or higher standard, demonstrably saving energy, water and other natural resources for the city and its residents. To carry these goals further, Ensemble/Mosaic has assembled a team of progressive design leaders, placemaking idea generators, and transportation futurists to create Philadelphia’s first LEED Certified Neighborhood Development at the Navy Yard.

LEED Neighborhood (LEED-ND) Development is a program engineered to inspire and help create better, more sustainable, well-connected neighborhoods, looking beyond the scale of buildings to consider entire communities. The Navy Yard will be one of the first of its kind designed with this new approach.

“One of the first things that really struck us as we went through the selection process for a development partner was Ensemble/Mosaic’s shared passion for the creation of an intentional and inclusive economic opportunity initiatives plan,” added McNamara. “We are excited that Ensemble/Mosaic quickly launched this plan concurrent with its development projects. This fresh approach will support the Navy Yard’s growth and positively impact generations of Philadelphia residents and businesses.”

 

Appendix 1: List of 21 MWVDBE Firms (alphabetized)

These firms are currently participating and are included in the $7.5M commitments in process.

 

Appendix 2: MWBE Representation Chart

Redevelopment of historic Building 624: Historic Core pedestrian plaza flanked by artisan makerspaces for authentic local retail. Credit: Groundswell

PIDC and Ensemble/Mosaic Execute Navy Yard Development Agreement, Launching $2.5 Billion Development Plan

Media Contacts: Robbie Tarpley Raffish, a.s.a.p.r. (for Ensemble/Mosaic) 410-430-9705; Jessica Calter, PIDC, 215-496-8161

PIDC, Philadelphia’s public-private economic development corporation and master developer of the Philadelphia Navy Yard, in partnership with Ensemble Real Estate Investments and Mosaic Development Partners, today announced the execution of an agreement which provides Ensemble/Mosaic with the exclusive development rights for 109 acres at the Navy Yard and launches a $2.5 billion development plan that will create thousands of construction and permanent jobs.

The $400 million first phase includes development of two advanced life sciences buildings followed by significant residential and hospitality initiatives. Ensemble/Mosaic will construct a +/-100,000 square foot speculative laboratory and office development at 1201 Normandy Place with anticipated delivery by the close of 2022. The partners will concurrently market 333 Rouse Boulevard, which can accommodate a 120,000 square foot build-to-suit facility, for opportunities with cGMP (current Good Manufacturing Practice) manufacturers. Upon completion of these buildings the Navy Yard will eclipse one million square feet of life sciences space.

“Execution of the development agreement with Ensemble and Mosaic and commencement of their initial life sciences projects will launch the next exciting chapter of development at the Navy Yard.  Expanding this vibrant life sciences hub will bring high quality jobs to the Navy Yard, support growing companies in the advanced life sciences sector, and contribute to development of this dynamic campus that is already home to 15,000 employees,” said Kate McNamara, Senior Vice President, PIDC. “Equally exciting, our agreement includes one of the most intentional and inclusive economic opportunity initiatives in the history of this city.”

Ensemble Owned and Ensemble Mosaic Development Rights at the Navy Yard

Mosaic Development Partners is a Philadelphia based firm which specializes in commercial and mixed-use development. Since 2012, Mosaic has secured and invested more than $120 million in Philadelphia neighborhoods, bringing quality retail, commercial, recreational, and residential space to communities of color, along with hundreds of construction and full-time jobs.

Smallwood-Lewis said, “For the last eight years, Mosaic has built profitably with community and cultural sensitivity in mind, and this project is in many ways a culmination of our experience to date. The next phase of development Navy Yard represents a unique opportunity to build community and add density, while making the most of the waterfront access and incredible open spaces that have already grown in use and importance during this past year. It is an exciting time, and we are pleased to partner with PIDC and Ensemble in this effort.”

The agreement, which was initially announced last July, will guide the growth and expansion of the former military base and will further establish the Navy Yard as a vibrant and inclusive mixed-use community. Ensemble/Mosaic ultimately envisions approximately 3,000 residential units and nearly three million square feet of life science manufacturing, R&D, office, hotels, makerspace and retail space when complete.

Phase One of Ensemble/Mosaic development at the Navy Yard

Expanding Life Science Capacity is a Top Priority

The building at 1201 Normandy Place is designed by DIGSAU, an award-winning contemporary architecture firm, in collaboration with CRB, a global architecture and engineering firm, which together aims to set a new standard for innovation. Philadelphia-based DIGSAU has designed five buildings in the Navy Yard. CRB is a preeminent designer for life science manufacturing and laboratory environments.

The four-story facility targeting LEED Gold certification is conceived with flexibility at the forefront. Its 30,000 square foot floor plates with 16’ floor-to-floor heights will provide lab and clinical manufacturing-ready environments for ATMP (advanced therapy medicinal products) and life science companies. Spaces between 5,000 to 100,000 square feet will be available, maximizing both efficiency and optionality for the company’s operations.

“Located minutes from University City, the home of cell and gene therapy research, the Navy Yard is a critical component in the growth of life science companies in the region. It will allow companies to incubate, commercialize and manufacture within 15 minutes of each other and an international airport,” said Seltzer. “Our new buildings will create much-needed inventory for the incredible demand for space in this sector.”

The preliminary concept for 333 Rouse Boulevard is a 120,000 square foot facility providing office, laboratory space, cGMP manufacturing, warehousing and conditioned indoor mechanical space for plant and critical utilities. The manufacturing area will support interior ceiling heights up to 16’ and provide floor heights designed to facilitate cGMP manufacturing with walkable cleanroom ceiling systems.

The project provides for a balance of short-term efficiency and long-term flexibility, making it an ideal home to life sciences companies seeking immediate functionality and the ability to grow in place. This project is being designed by DIGSAU and IPS-Integrated Projects Services, LLC, a locally founded company that ranks as one of the top biologics, cell and gene therapy design firms in the world solely dedicated to designing, constructing and qualifying cGMP facilities.

Diversity, Equity, and Inclusion Strategy Drives Development

A key aspect of the vision of this dynamic and vibrant campus is that it provides opportunities for all Philadelphians. To that end, the partners are committed to deploying a robust and novel approach to diversity, equity, and inclusion in all elements of the 109 acres in the agreement.

“From the teams we assemble to design and build the buildings, to the projects and people who will occupy them, the Navy Yard will be a more inclusive place for all,” said Reaves. “Our collective goal is to create a national model that combines institutional development and inclusive strategies in new and exciting ways.”

This holistic inclusion strategy provides tremendous opportunities for minority- and women-owned business enterprise (M/WBE) participation. This will include diverse equity ownership with an innovative crowd-funding component, substantial M/WBE participation in construction and operations, inclusion of local and M/WBE small businesses in retail and makerspace opportunities, a paid internship program with Cheyney University, and the allocation of a share of net income to a charitable foundation that will create new opportunities for young people in Philadelphia. Additional details will be released at another time.

“These and other initiatives will attract female and minority students in high school and college from across the region and the country who are interested in pursuing a career in commercial real estate, construction, architecture and design. It’s not just about planning and building for now, it’s about doing so for the future, too,” Reaves added.

Background

In September 2019, PIDC put out a call for prospective partners through a Request for Qualifications (RFQ). PIDC received more than 35 responses to the RFQ in December 2019. Based on the RFQ criteria, five highly experienced teams were shortlisted and invited to submit full proposals in response to a comprehensive Request for Proposals (RFP). After detailed review and evaluation of the proposals and virtual team interviews with an Advisory Panel, PIDC selected the Ensemble/Mosaic co-development team in July 2020.

In January 2021, PIDC and Ensemble/Mosaic released a Request for Proposals (RFP) opportunity for large-scale comprehensive master planning at the Navy Yard. The team sought proposals from qualified, experienced, diverse, and inclusive planning, design, and engineering firms to develop and deliver a comprehensive master plan. The 2021 Navy Yard Master Plan Update will establish a dynamic, cohesive, and achievable placemaking vision and development framework as the Navy Yard embarks on its next phase of expansion and growth. An announcement about the master plan firm will be made in the coming weeks.

PIDC retained JLL in early 2019 to advise in this selection of a development partner. JLL supported PIDC throughout the RFQ and RFP processes, and assisted PIDC with development agreement negotiations.

Click for additional information about PIDC, the Navy Yard, Ensemble, or Mosaic.

Riverfront_Greenway_NY_1017_Shot_01_0106_PRINT_WORKING_

Philadelphia Navy Yard Development Team Releases Request for Proposals Seeking Firms to Update Master Plan

Download press release as PDF: Navy Yard Master Plan RFP – 01.04.2021 – final

Update 1/12/21: Register for the Pre-Bid Meeting on Friday, January 15 at 9-11AM on Zoom.

PIDC, Philadelphia’s public-private economic development corporation, in partnership with Ensemble Real Estate Investments and Mosaic Development Partners (“Ensemble/Mosaic”), has released a Request for Proposals (RFP) opportunity for large-scale comprehensive master planning at the Philadelphia Navy Yard. PIDC and Ensemble/Mosaic seek proposals from qualified, experienced, diverse, and inclusive planning, design, and engineering firms to develop and deliver a comprehensive master plan. The 2021 Navy Yard Master Plan Update will establish a dynamic, cohesive, and achievable placemaking vision and development framework as the Navy Yard embarks on its next phase of expansion and growth.

Read more

This opportunity comprises the next stage of development at the Navy Yard, focused on bringing expanded life sciences R&D and production, corporate headquarters, office and commercial, retail and restaurant amenities, and for the first time, mixed-use residential buildings, to 109 acres of the Navy Yard’s Historic Core and Mustin Districts

PIDC Announces Philadelphia Navy Yard Development Partner Shortlist

PIDC, Philadelphia’s public-private economic development corporation, received over 35 responses to the request for qualifications (RFQ) issued last fall for development of 109 acres at the Philadelphia Navy Yard. This opportunity comprises the next stage of development at the Navy Yard, focused on bringing expanded life sciences R&D and production, corporate headquarters, office and commercial, retail and restaurant amenities, and for the first time, mixed-use residential buildings, to the Navy Yard’s Historic Core and Mustin Districts. From the diverse mix of experienced local and national developers who responded, PIDC has created a shortlist of highly attractive prospective partners who have been invited to submit detailed proposals in a request for proposal (RFP) stage, with final selection of a partner to be made later this year.  Read more

300 Rouse Boulevard, view from Central Green. Credit: DIGSAU

Iovance Biotherapeutics Announces New Facility at the Navy Yard to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it has entered into a lease agreement to build an approximately 136,000 square foot commercial-scale production facility at the Philadelphia Navy Yard for commercial and clinical production of autologous TIL products, including its candidate lifileucel. Read more

R_Hjortshoj-1200Intrepid

Liberty Property Trust Brings Worldwide Express to 1200 Intrepid Avenue in the Navy Yard

Philadelphia, PA – September 6, 2018 – Liberty Property Trust has leased 4,612 square feet at 1200 Intrepid Avenue to Worldwide Express, one of the top logistics companies in North America.

Read more